TCI Wealth Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-210
Closed -$17.4K 1049
2023
Q1
$17.4K Hold
210
﹤0.01% 788
2022
Q4
$16.5K Hold
210
﹤0.01% 791
2022
Q3
$16K Buy
210
+3
+1% +$215 ﹤0.01% 765
2022
Q2
$13K Hold
207
﹤0.01% 851
2022
Q1
$13K Buy
207
+187
+935% +$10.2K ﹤0.01% 928
2021
Q4
$1K Sell
20
-112
-85% -$6.82K ﹤0.01% 2199
2021
Q3
$9K Sell
132
-12
-8% -$757 ﹤0.01% 1166
2021
Q2
$10K Buy
144
+124
+620% +$8.77K ﹤0.01% 961
2021
Q1
$2K Hold
20
﹤0.01% 1757
2020
Q4
$2K Hold
20
﹤0.01% 1214
2020
Q3
$2K Hold
20
﹤0.01% 1115
2020
Q2
$2K Hold
20
﹤0.01% 1060
2020
Q1
$2K Hold
20
﹤0.01% 1020
2019
Q4
$2K Hold
20
﹤0.01% 1148
2019
Q3
$3K Hold
20
﹤0.01% 954
2019
Q2
$2K Hold
20
﹤0.01% 1015
2019
Q1
$2K Hold
20
﹤0.01% 1030
2018
Q4
$2K Sell
20
-8
-29% -$840 ﹤0.01% 1000
2018
Q3
$3K Sell
28
-16
-36% -$1.66K ﹤0.01% 920
2018
Q2
$4K Buy
44
+24
+120% +$2.03K ﹤0.01% 846
2018
Q1
$1K Hold
20
﹤0.01% 1148
2017
Q4
$1K Hold
20
﹤0.01% 1196
2017
Q3
$1K Hold
20
﹤0.01% 1119
2017
Q2
$1K Hold
20
﹤0.01% 1138
2017
Q1
$1K Hold
20
﹤0.01% 1098
2016
Q4
$1K Hold
20
﹤0.01% 1167
2016
Q3
$1K Hold
20
﹤0.01% 1128
2016
Q2
$1K Buy
+20
New +$605 ﹤0.01% 1067

Other funds holding HAE

TCI Wealth Advisors's HAE Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Haemonetics (HAE) in Q2 2023, closing a stake of 210 shares — an estimated $17.4K sold.

TCI Wealth Advisors first reported a position in HAE in Q2 2016 and held it in 28 quarters. The position peaked at $17.4K in Q1 2023. 294 funds tracked by Wall St. Rank hold HAE as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Haemonetics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 210 Haemonetics shares in Q2 2023, an estimated $17.4K.
  • TCI Wealth Advisors first reported a position in Haemonetics in Q2 2016 and held it in 28 quarters.
  • TCI Wealth Advisors's Haemonetics position peaked at $17.4K in Q1 2023.
  • 294 funds tracked by Wall St. Rank held Haemonetics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.